VEGFA SNP rs2010963 is associated with vascular toxicity in recurrent glioblastomas and longer response to bevacizumab-Reference-Cited by-同舟云学术

VEGFA SNP rs2010963 is associated with vascular toxicity in recurrent glioblastomas and longer response to bevacizumab

Published:2014-12-07 Issue:3 Volume:121 Page:499-504
ISSN:0167-594X
Container-title:Journal of Neuro-Oncology
language:en
Short-container-title:J Neurooncol

Author:

Di Stefano Anna Luisa,Labussiere Marianne,Lombardi Giuseppe,Eoli Marica,Bianchessi Donata,Pasqualetti Francesco,Farina Patrizia,Cuzzubbo Stefania,Gallego-Perez-Larraya Jaime,Boisselier Blandine,Ducray Francois,Cheneau Caroline,Moglia Arrigo,Finocchiaro Gaetano,Marie Yannick,Rahimian Amithys,Hoang-Xuan Khe,Delattre Jean Yves,Mokhtari Karima,Sanson Marc

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Clinical Neurology,Neurology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s11060-014-1677-x.pdf

Reference27 articles.

1. Kunnakkat S, Narayana A (2011) Bevacizumab in the treatment of high-grade gliomas: an overview. Angiogenesis 14:423–430

2. Jensen RL (1998) Growth factor-mediated angiogenesis in the malignant progression of glial tumors: a review. Surg Neurol 49:189–195; discussion 196

3. Friedman HS, Prados MD, Wen PY et al (2009) Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma. J Clin Oncol 27:4733–4740

4. Kreisl TN, Kim L, Moore K et al (2009) Phase II trial of single-agent bevacizumab followed by bevacizumab plus irinotecan at tumor progression in recurrent glioblastoma. J Clin Oncol 27:740–745

5. Vredenburgh JJ, Desjardins A, Herndon JE 2nd et al (2007) Bevacizumab plus irinotecan in recurrent glioblastoma multiforme. J Clin Oncol 25:4722–4729

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetic insights and emerging therapeutics in diabetic retinopathy: from molecular pathways to personalized medicine;Frontiers in Genetics;2024-08-22

2. VEGFA contributes to tumor property of glioblastoma cells by promoting differentiation of myeloid-derived suppressor cells;BMC Cancer;2024-08-22

3. Inherited thrombophilia gene mutations and risk of venous thromboembolism in patients with cancer: A systematic review and meta‐analysis;American Journal of Hematology;2024-01-30

4. Genetic Variability in VEGFA Gene Influences the Effectiveness of Tennis Elbow Therapy with PRP: A Two-Year Prospective Cohort Study;International Journal of Molecular Sciences;2023-12-09

5. Association of single nucleotide variants in VEGFA and KDR with the risk and angiogenic features of diffuse large B-cell lymphoma;Leukemia & Lymphoma;2023-08-30